JPRN-UMIN000008677
Completed
未知
Efficacy and Safety of treatment with Levofloxacin for Community-acquired Pneumonia - Levofloxacin Therapy for Community-acquired Pneumonia
Second Division, Department of Internal Medicine, Hamamatsu university school of medicine0 sites300 target enrollmentAugust 14, 2012
ConditionsCommunity-acquired pneumonia in adults
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Community-acquired pneumonia in adults
- Sponsor
- Second Division, Department of Internal Medicine, Hamamatsu university school of medicine
- Enrollment
- 300
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients who took respiratory quinolones for current pneumonia. 2\.Patients who are prohibited to take levofloxacin. 3\.Patients with liver dysfunction AST:more than three times the upper limit of normal ALT:more than three times the upper limit of normal T\-bil:more than three times the upper limit of normal 4\.Patients witg renal dysfunction (Cre is over than 3\.0mg/dl, or Ccr is less than 30 mL/min/1\.73m2\) 5\.Patients who has disease of central nervous system and expected spasm. 6\.Patient whom conducting of the examination doctor judged inappropriate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in KoreaHelicobacter pylori infectionJPRN-UMIN000015375Severance Hospital, Yonsei University200
Recruiting
Not Applicable
Comparison of Levofloxacin/Colistin with Levofloxacin/high dose Ampicillin-sulbactam infusion in treatment of Ventilator-Associated Pneumonia due to multi drug resistant AcinetobacterIRCT20120703010178N15Shahid Beheshti University of Medical Sciences56
Completed
Not Applicable
Efficacy and safety of levofloxacin infusion in patients with NHCAP categorized as group B or C according to the JRS Guidelines for the Management of Hospital-Acquired Pneumonia in AdultsJPRN-UMIN000011837Department of Respiratory Medicine,University of Occupational and Environmental Health, Japan60
Recruiting
Phase 3
The effectiveness of levofloxacin in prevention of febrile episodes in non-Hodgkin lymphoma patients receiving R-CHOPFebrile episode in non-Hodgkin lymphomaFebrile episodeNon-Hodgkin lymphomaLevofloxacinR-CHOPTCTR20230719005Ratchadapisek Research Funds72
Recruiting
Phase 4
Pharmacokinetic study and safety of levofloxacin in pediatric tuberculosis treatmentMulti-drug resistant tuberculosisIsoniazid resistant tuberculosispatient with toxicity from the first line antituberculosisMDR-TBHr-Toxicity from the first line anti-LevofloxacinTCTR20190515001Center of Excellence for Pediatric Infectious Diseases and Vaccines20